Novel vaccine formulations

Details for Australian Patent Application No. 2006236711 (hide)

Owner Merial Limited

Inventors Parisot, Alexis Guy Andre; Charreyre, Catherine; Desgouilles-Blechet, Stephanie Marie-Catherine; Roulet, Claude Jean Marie

Agent FB Rice

Pub. Number AU-B-2006236711

PCT Pub. Number WO2006/113373

Priority 11/107,000 15.04.05 US

Filing date 13 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 29 July 2010

International Classifications

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

Event Publications

8 November 2007 PCT application entered the National Phase

  PCT publication WO2006/113373 Priority application(s): WO2006/113373

29 July 2010 Application Accepted

  Published as AU-B-2006236711

25 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236714-2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (IAP) modulators

2006236704-Hybrid LVEDP monitor